Pharmacy Healthcare Solutions Inc. (PHSI) consults with pharmaceutical manufacturers, PBMs, retail pharmacy chains, and software companies on strategic business and marketing issues. Consulting projects across these market segments provide PHSI with the latest information on emerging trends as well as new products and services. Our consultants have extensive retail, mail service and managed care experience to create actionable recommendations for our clients’ challenging business issues.
PHSI President Tim Kosty and Vice President Don Dietz will be attending the Pittsburgh Business Group on Health (PBGH) Annual Health Care Symposium on Thursday, September 10, 2015 in Pittsburgh, PA. To learn more about the event and PBGH, visit http://www.pbghpa.com.
PHSI Consultants Alan Sekula and Ann Johnson contributed to the May/June 2015 edition of ComputerTalk for the Pharmacist. In their Viewpoints article, Alan and Ann review the impact that biosimiliars will have on various stakeholders: drug compendia, payers, wholesalers, pharmacies, and manufacturers.
PHSI Consultant Dave Schuetz contributed to the March/April 2015 edition of ComputerTalk for the Pharmacist. In his Viewpoints article, Dave discusses the challenges surrounding e-prescribing of controlled substances and responsibilities that pharmacies have when utilizing the process and pharmacy system. Click here to read Dave’s article entitled “E-Prescriptions Leading to Uncharted Waters”.
On July 13, the Drug Enforcement Administration (DEA) announced the reinstatement of Drug Take-Back Days, with the 10th Take-Back Day scheduled for September 26, 2015 in 48 states; Take-Back Days in Pennsylvania and Delaware will take place on September 12. Visit https://www.deadiversion.usdoj.gov/SEARCH-NTBI/ to locate a collection site near you. Termination and Reinstatement of DEA-Sponsored Take-Back Read More →
On May 20, 2015, Dr. Karen Thacker of the Allegheny County Health Department issued a press release announcing a standing order to allow pharmacists in Allegheny County (Pennsylvania) to dispense intranasal and injectable naloxone without a prescription to at-risk patients and caregivers. This standing order is allowed by Pennsylvania Act 139, which was passed in Read More →
CMS issued a new guidance on biosimilar reimbursement. It sounds simple but now the drug compendia must link the biosimilar with the originator or someone else will meet this marketplace need.